News

  • iPS-based regenerative medicine is shifting from experimental promise to structured implementation

    iPS based therapies are no longer just a promise of regenerative medicine but are approaching real world clinical implementation. For those of us working in stem cell biology, 3D cell culture, biomaterials, or translational regenerative medicine, this is an exciting and clear indicator of where the field is moving 🧬 Japan’s expert panel has endorsed…

  • faCellitate Launches new BIOFLOAT™ 1536-Well ULA Plate, Making 3D Cell Culture Even Easier and More Reproducible

    faCellitate announced the launch of the BIOFLOAT™ 1536-well ultra-low-attachment (ULA) plate, engineered to deliver rapid, uniform spheroids and reproducible, high-density High-throughput Screening (HTS) readouts to simplify day-to-day 3D cell culture.  With this step, faCellitate reinforces its product portfolio and reaffirms its commitment to supporting researchers in drug development worldwide. By delivering cutting-edge surface technologies,…

  • Introducing BIOINSTRUCT™ — Revolutionising Stem Cell Culture

    Mannheim, Germany – faCellitate GmbH is proud to announce the launch of BIOINSTRUCT™, a groundbreaking synthetic coating designed to enhance the growth and maintenance of human induced pluripotent stem cells (iPSCs). This innovative product promises to transform stem cell culture with its robust performance, purity, and predictability.  BIOINSTRUCT™ provides a defined, xeno-free microenvironment that…

  • faCellitate GmbH Welcomes Industry Veteran to Advisory Board

      Mannheim, December 2024 – faCellitate GmbH, a leading innovator in the field of defined surface coatings for life science consumables is thrilled to welcome Heinz Schmid, a renowned and globally recognized expert in the industry, to its advisory board. Heinz Schmid served 19 years as Managing Director of Greiner Bio-One Germany and 13…

  • faCellitate 2023: Cutting-edge Flat-Bottom microplates with Ultra-Low Adhesion Surface

    faCellitate expands its product range with the launch of three new BIOFLOAT™ –coated flat-bottom microplates; a 96-well format, soon to be followed by 24- and 6-well plates. This innovative series is purposefully crafted as an addition to the BIOFLOAT 96-well and 384-well U-Bottom plates, catering to spheroid and organoid applications. The BIOFLOAT coated flat-bottom microplate sets…

  • Spheroid Models To Study Lung Cancer

    Spheroid model has been shown to have features consistent with patient specific Non-Small Cell Lung Cancer Spheroid tumours (NSCLC), characterised by extremely high clonal and morphological heterogeneity of tumours and multi-drug resistance. Lung malignancies accounts for 11% of cancer worldwide and remained leading cause of cancer deaths. Spheroids strongly depends on the cell composition…

  • Characterization Of Multicellular Tumor Spheroids

    Multicellular tumor (MCT) spheroids are an essential tool in tumor related research, and drug screens. MCT can be defined as aggregates of heterogeneous cells, closely packed with highly dense spheroids. These cells exhibit strong cell-cell and cell-extracellular matrix (ECM) interactions representative of in vivo tumor physiology (1-2). However it if of importance to monitor…